Relationship between serum calcium or phosphate levels and mortality stratified by parathyroid hormone level: an analysis from the MBD-5D study
Open Access
- 31 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Clinical and Experimental Nephrology
- Vol. 24 (7), 630-637
- https://doi.org/10.1007/s10157-020-01879-8
Abstract
Introduction There is limited evidence about the association between calcium and phosphate levels and mortality stratified by intact parathyroid hormone (iPTH) level. Methods We investigated whether differences in iPTH level affect the relationship between calcium and phosphate levels and all-cause mortality in hemodialysis patients with secondary hyperparathyroidism (SHPT). Calcium and phosphate levels were categorized as low (< 8.5 mg/dL, < 4.0 mg/dL), medium (≥ 8.5–< 9.5 mg/dL, ≥ 4.0–< 7.0 mg/dL), and high (≥ 9.5 mg/dL, ≥ 7.0 mg/dL), respectively. iPTH levels were grouped into < 300 or ≥ 300 pg/mL. Adjusted incidence rate ratios (aIRRs) were analyzed by weighted Poisson regression. Results For calcium, patients with higher iPTH (≥ 300 pg/mL) had significantly higher all-cause mortality rates in the high than in the medium category (aIRR 1.99, 95% confidence interval [CI] 1.16–3.42), and tended to have a higher mortality rate in the low category (aIRR 2.04, 95% CI 0.94–4.42). Patients with lower iPTH (< 300 pg/mL) had higher mortality rates in the high than in the medium category (aIRR 1.65, 95% CI 1.39–1.96). For phosphate, the mortality rate was significantly higher in the high than in the medium category in patients with higher and lower iPTH (aIRR 3.23, 95% CI 1.63–6.39 for iPTH ≥ 300 pg/mL; aIRR 1.58, 95% CI 1.06–2.36 for iPTH < 300 pg/mL). Conclusion High calcium and phosphate levels were associated with increased risk of mortality irrespective of iPTH level.Keywords
Funding Information
- Kyowa Kirin
This publication has 14 references indexed in Scilit:
- Abnormal Mineral Metabolism and Mortality in Hemodialysis Patients With Secondary Hyperparathyroidism: Evidence From Marginal Structural Models Used to Adjust for Time-Dependent ConfoundingAmerican Journal of Kidney Diseases, 2014
- Serum Phosphate and Calcium Should Be Primarily and Consistently Controlled in Prevalent Hemodialysis PatientsTherapeutic Apheresis and Dialysis, 2013
- Mineral and Bone Disorders Outcomes Study for Japanese Chronic Kidney Disease Stage 5D Patients: Rationale and Study DesignTherapeutic Apheresis and Dialysis, 2011
- Clinical Practice Guideline for the Management of Secondary Hyperparathyroidism in Chronic Dialysis PatientsTherapeutic Apheresis and Dialysis, 2008
- Mortality Risk for Dialysis Patients With Different Levels of Serum Calcium, Phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS)American Journal of Kidney Diseases, 2008
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE)Clinical Journal of the American Society of Nephrology, 2007
- Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)Kidney International, 2006
- Mineral Metabolism, Mortality, and Morbidity in Maintenance HemodialysisJournal of the American Society of Nephrology, 2004
- Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive MenEpidemiology, 2000
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973